Cargando…

Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations—A Social Epidemiology Counterargument

Detalles Bibliográficos
Autores principales:	Cainzos-Achirica, Miguel, Bilal, Usama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237894/ https://www.ncbi.nlm.nih.gov/pubmed/32442515 http://dx.doi.org/10.1016/j.amjmed.2020.04.017

Ejemplares similares

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

Cardiovascular risk perception in women: true unawareness or risk miscalculation?
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2015)

Strengths and Limitations of Using the Polypill in Cardiovascular Prevention
por: Roy, Ambuj, et al.
Publicado: (2017)

Inequalities by Income in the Prevalence of Cardiovascular Disease and Its Risk Factors in the Adult Population of Catalonia
por: Mullachery, Pricila H., et al.
Publicado: (2022)

The Evolving Landscape of Cardiovascular Disease Prevention
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2021)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

SARS-COV-2 as an artificial creation: scientific arguments and counterarguments
por: Yee, Shermaine, et al.
Publicado: (2021)

Resistance strategies and attitude certainty in persuasion: bolstering vs. counterarguing
por: Blankenship, Kevin L., et al.
Publicado: (2023)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Differences in Uptake of Risk Reduction Strategies Among Underserved Populations
por: Lynce, Filipa, et al.
Publicado: (2015)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
por: Soliman, Elsayed Z, et al.
Publicado: (2011)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
por: Lopez-Lopez, Jose P, et al.
Publicado: (2023)

Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease
por: Wood, Frances, et al.
Publicado: (2015)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

Commentary: Innovations in technology hold promise for glaucoma detection in underserved populations
por: Choudhari, Nikhil S, et al.
Publicado: (2021)

Medicinal herbs: Potential polypills in cardiovascular diseases
por: Noroozi, Samaneh, et al.
Publicado: (2021)

Cardiovascular Disease Prevention During the COVID-19 Pandemic: Lessons Learned and Future Opportunities
por: Duffy, Eamon, et al.
Publicado: (2021)

Telehealth Training Is Essential to Care for Underserved Populations: a Medical Student Perspective
por: Camhi, Stephanie S., et al.
Publicado: (2020)

Counterargument to the editor’s letter about the article “Evaluation of functional disability after Chikungunya infection”
por: Panato, Cristiane Silvia, et al.
Publicado: (2020)

Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke
por: Wald, Nicholas J., et al.
Publicado: (2016)

Could patents interfere with the development of a cardiovascular polypill?
por: Beall, Reed F., et al.
Publicado: (2016)

Redefining the polypill: pros and cons in cardiovascular precision medicine
por: Birla, Siddharth, et al.
Publicado: (2023)

Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular, Metabolic and Renal Conditions: A Population-Based Analysis
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Implications of the 2021 ESC cardiovascular risk classification among 283,000 European immigrants living in a low-risk region: a population-based analysis in Catalonia
por: Vela, Emili, et al.
Publicado: (2021)

The Effectiveness of Polypill for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials
por: Virk, Ghazala S, et al.
Publicado: (2023)

Polypill eligibility and equivalent intake in a Swiss population-based study
por: Castioni, Julien, et al.
Publicado: (2021)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Cardiovascular Health, Adiposity, and Food Insecurity in an Underserved Population
por: Myers, Candice A., et al.
Publicado: (2019)

The polypill approach – An innovative strategy to improve cardiovascular health in Europe
por: Fuster, Valentín, et al.
Publicado: (2017)

RADx-UP Testing Core: Access to COVID-19 Diagnostics in Community-Engaged Research with Underserved Populations
por: Narayanasamy, Shanti, et al.
Publicado: (2023)

Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country
por: Yan, Lily D., et al.
Publicado: (2022)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review
por: Jahangiri, Reza, et al.
Publicado: (2022)

Pharmacist-Led Chronic Care Management for Medically Underserved Rural Populations in Florida During the COVID-19 Pandemic
por: Como, Madison, et al.
Publicado: (2020)

An under-represented and underserved population in trials: methodological, structural, and systemic barriers to the inclusion of adults lacking capacity to consent
por: Shepherd, Victoria
Publicado: (2020)

The Polypill: From Promise to Pragmatism
por: Huffman, Mark D.
Publicado: (2015)

Polypill revisited – Unity in diversity
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2020)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention()
por: Wang, Frances M., et al.
Publicado: (2023)

Adoption and scale-up of the cardiovascular Polypill: a realist institutional analysis
por: Abimbola, Seye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5oktdlkt814fsloot1daql7fp4